Photodynamic Therapy with Intravitreal Triamcinolone in Predominantly Classic Choroidal Neovascularization. One-Year Results of a Randomized Study

Luis Arias, J. Garcia-Arumi, J. M. Ramon, M. Badia, M. Rubio, O. Pujol

Research output: Contribution to journalArticleResearchpeer-review

63 Citations (Scopus)

Abstract

Purpose: To determine whether intravitreal triamcinolone acetonide (IVTA) improves the efficacy of photodynamic therapy (PDT) with verteporfin in predominantly classic subfoveal choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD). Design: Prospective randomized study. Participants: Sixty-one patients with predominantly classic subfoveal CNV secondary to AMD. Methods: Patients were randomized to receive PDT (n = 30) or PDT followed by approximately 11 mg IVTA (n = 31), with retreatment every 3 months when leakage was documented by fluorescein angiography. At baseline and each follow-up visit, best-corrected visual acuity (VA) was measured with Early Treatment Diabetic Retinopathy Study charts by a certified examiner masked to the patient's treatment, lesion size on fluorescein angiography, and foveal thickness on optical coherence tomography. Main Outcome Measures: Mean change in VA (logarithm of the minimum angle of resolution [logMAR]) from baseline, percentage of patients losing fewer than 15 letters (3 lines) of VA, mean change in lesion size, mean change in foveal thickness, and retreatment rate. Results: At the 12-month follow-up, VA (mean logMAR change from baseline) was significantly better (P = 0.001) in the group of patients who received combined therapy. Seventy-four percent of patients treated with combined therapy compared with 61% treated with verteporfin alone lost fewer than 15 letters of VA (P = 0.78). Reduction in lesion size (P = 0.001) and in foveal thickness (P = 0.03) was significantly greater with combined therapy than with verteporfin. Retreatment rate was significantly lower (P = 0.04) in the combined therapy group. Triamcinolone-related adverse events included glaucoma (25.8%) and cataract progression (32%). Conclusions: Combined PDT and IVTA therapy seemed to be more effective than PDT alone for managing predominantly classic subfoveal lesions secondary to AMD. The triamcinolone-related adverse events included glaucoma and cataract progression. © 2006 American Academy of Ophthalmology.
Original languageEnglish
Pages (from-to)2243-2250
JournalOphthalmology
Volume113
DOIs
Publication statusPublished - 1 Dec 2006

Fingerprint

Dive into the research topics of 'Photodynamic Therapy with Intravitreal Triamcinolone in Predominantly Classic Choroidal Neovascularization. One-Year Results of a Randomized Study'. Together they form a unique fingerprint.

Cite this